MYRIAD GENETICS, INC. MYGN Cash Flow

Myriad genetics, inc. (MYGN)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10	Dec'09	Sep'09
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss) attributable to Myriad Genetics, Inc. stockholders
-148,300	-26,200	-15,300	4,600	23,200	25,500	53,800	133,300	127,300	122,400	97,400	17,400	0	0	0	-	-	-	-	80,200	95,107	110,375	136,735	176,200	186,728	187,853	172,529	147,200	132,207	123,929	117,188	112,151	109,049	107,375	103,271	100,710	127,920	133,230	144,399	152,303	0	0	0
Net Income attributable to Myriad Genetics, Inc. stockholders
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization
72,700	73,100	72,900	73,000	69,700	64,400	59,500	54,400	52,600	52,500	52,300	48,300	41,700	35,300	29,100	26,700	26,600	26,500	25,800	25,000	23,909	20,989	17,428	13,800	10,556	9,256	9,061	8,900	8,963	9,086	9,133	9,069	8,619	8,116	7,609	7,219	7,133	7,111	7,062	7,084	0	0	0
Non-cash interest expense
400	1,800	1,800	400	400	-1,100	-1,200	200	100	200	400	400	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on disposition of assets
200	100	0	900	1,200	1,200	1,100	200	0	0	200	300	700	700	700	900	0	0	0	-	-	-	-960	-900	0	0	0	-	0	0	0	-	-	-	0	-	-	-	-	-496	0	0	0
Share-based compensation expense
32,100	34,100	34,600	33,500	31,800	29,000	28,400	27,100	27,200	28,000	28,500	29,900	30,400	30,500	30,700	31,600	38,000	43,000	47,500	45,700	38,197	32,308	27,065	27,100	26,668	26,688	26,935	26,600	26,851	26,708	26,211	26,275	26,232	25,868	25,379	25,088	24,518	23,271	23,771	22,776	0	0	0
Bad debt expense
-	-	-	-	-	-	-	-	-	-	-	-	37,100	36,900	34,500	33,300	31,500	32,000	30,400	31,500	31,732	31,407	34,806	39,200	41,165	40,364	37,599	33,300	30,354	28,882	27,679	24,742	21,336	18,222	16,080	16,182	17,076	17,775	18,415	18,476	0	0	0
Deferred income taxes
7,300	-9,500	-10,800	-18,600	-4,400	-4,700	25,500	23,500	26,100	28,000	-2,300	-800	11,400	8,800	-9,900	-18,100	-32,100	-27,500	-8,300	400	-5,273	-11,826	-11,388	-8,100	-4,207	325	-4,588	-7,400	-4,446	-8,250	-21,063	-33,625	-47,764	-58,547	-55,404	-53,156	0	0	0	-	-	-	-
Unrecognized tax benefits
-2,400	2,500	2,500	5,500	10,300	10,800	9,600	300	-4,800	-10,000	-8,300	-1,200	900	-3,300	-2,900	-2,400	-2,200	2,500	2,700	2,100	-1,723	-2,200	-2,038	-700	3,153	3,170	2,208	700	0	0	0	-	-	-	-	-148	0	0	0	-	-	-	-
Change in fair value of contingent consideration
2,800	700	-300	-1,400	-1,000	-2,100	11,900	-60,900	-64,100	-57,800	-74,500	-800	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accreted interest on note receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,300	4,037	2,700	2,699	2,700	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Excess tax benefit from share-based compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,400	9,191	13,108	12,786	11,100	7,744	4,869	7,451	7,900	7,261	6,327	17,616	34,193	46,846	62,627	63,513	58,831	0	0	0	-	-	-	-
Gain on sale of marketable investment securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	566	604	81	20	3	201	485	460	397	0	0	0
Changes in assets and liabilities:
Prepaid expenses
1,700	4,200	2,400	3,200	-2,600	-1,200	-1,900	-3,300	400	-2,400	-3,200	-7,800	-12,400	1,700	6,400	7,200	11,200	1,900	-4,000	5,500	7,663	8,107	9,106	5,500	215	-2,106	-1,737	-800	-606	-1,871	-1,741	-1,204	1,455	1,407	-166	412	-674	-2,706	4,925	61	0	0	0
Trade accounts receivable
-38,300	3,700	-1,800	18,200	21,700	-3,000	6,200	9,100	-26,400	-11,900	-200	-500	50,800	52,500	41,500	39,200	30,900	31,600	36,500	34,400	39,293	26,703	22,521	24,400	28,673	48,946	61,319	67,200	72,634	61,457	45,396	34,986	22,132	17,487	13,380	14,918	15,394	9,069	25,588	21,660	0	0	0
Other receivables
-600	-900	500	700	3,400	2,200	-500	-1,100	-3,300	200	1,900	4,000	3,100	-2,000	2,900	900	-600	1,200	-10,200	-2,500	413	3,328	10,958	1,900	1,760	2,544	-168	700	687	24	1,543	2,312	403	815	227	202	338	197	452	-22	0	0	0
Inventory
-	-4,500	-7,600	-8,000	-6,400	-9,900	-8,100	-7,900	-14,200	-13,300	-15,100	1,200	20,900	20,900	18,400	14,600	-3,900	8,600	9,100	800	0	0	0	-	-	-	-	-	-	-	-	3,426	0	0	0	-	-	-	-	-	-	-	-
Prepaid taxes
22,400	21,600	19,400	25,100	0	0	0	-	2,900	4,600	4,500	-3,400	-15,100	-23,800	-12,400	3,800	15,300	22,400	-1,500	-13,600	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts payable
7,100	-9,900	200	1,100	-2,100	700	-4,800	4,000	-7,000	2,000	2,400	-3,000	0	0	0	-	-3,600	-1,000	-11,000	-3,100	-2,265	-7,164	487	-1,500	268	4,030	7,668	8,000	4,304	4,687	1,272	-1,249	510	-395	339	287	-1,835	-2,353	-406	-5,307	0	0	0
Accrued liabilities
-15,300	-5,600	4,200	1,500	5,400	2,500	2,800	1,400	-800	400	5,400	1,200	-3,000	-4,000	-3,800	500	1,000	1,300	-3,300	-13,400	-6,167	-13,610	-27,756	3,100	3,787	16,690	16,432	11,600	10,648	5,593	22,915	11,218	6,493	4,431	1,890	924	2,989	2,829	1,815	-393	0	0	0
Deferred revenue
-	-	-	-500	-400	-1,100	-900	-100	-200	1,100	2,500	900	0	0	0	-	-	-	0	400	-823	-2,309	348	-1,100	0	0	0	-	1,662	293	2,214	748	0	0	0	-	-	-	-	-	-	-	-
Net cash provided by operating activities
62,200	52,000	91,700	83,700	100,100	105,000	100,200	115,900	104,600	134,200	132,600	106,200	126,000	129,000	133,600	166,300	160,900	146,700	163,300	140,500	130,420	111,769	106,718	190,200	212,314	238,461	213,026	173,900	152,569	155,920	161,336	141,804	136,474	123,763	133,358	130,830	140,979	155,599	161,201	155,086	0	0	0
CASH FLOWS FROM INVESTING ACTIVITIES
Capital expenditures
9,200	9,300	8,700	8,600	9,000	8,800	8,100	8,400	7,300	5,900	6,200	6,100	7,600	6,800	5,500	5,000	4,800	8,500	13,400	23,900	26,547	23,702	20,535	14,300	12,471	12,490	14,204	11,400	10,774	11,200	9,760	9,408	7,826	5,984	3,942	3,792	4,009	4,999	8,277	7,895	0	0	0
Acquisitions, net of cash acquired
-	-	-	278,500	0	0	0	-	-	-	-	216,100	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Purchases of marketable investment securities
82,300	86,900	87,200	78,500	58,500	56,200	63,800	80,900	92,300	99,800	86,800	87,500	107,700	112,800	174,900	164,500	157,000	158,800	96,600	80,700	111,449	81,739	107,558	161,800	267,477	307,197	377,039	443,800	378,987	467,473	473,688	388,067	377,044	356,436	418,916	425,153	485,480	485,924	469,909	477,558	0	0	0
Restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchase of an acquisition option
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8,000	0	0	0	-	-	-	-	-	-	-	-
Issuance of note receivable (Crescendo)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	17,000	0	0	0	-	-	-	-	-	-	-	-
Proceeds from maturities and sales of marketable investment securities
83,700	82,600	80,300	79,200	64,000	64,600	76,100	77,700	83,400	97,100	90,000	160,800	171,400	152,700	172,000	115,100	111,400	156,400	129,800	165,600	183,435	349,968	393,254	382,500	425,770	291,102	317,787	385,300	390,626	387,640	442,937	385,236	399,784	463,631	456,579	456,072	509,608	454,833	416,679	408,585	0	0	0
Net cash provided by (used in) investing activities
13,500	-13,600	-14,500	-286,400	-282,000	-278,900	-275,400	-11,600	-16,200	-6,000	-3,500	-146,300	-194,400	-220,000	-258,400	-91,400	-50,400	-9,400	22,400	40,900	25,370	-573	18,961	-17,100	-82,709	-33,585	-78,456	-74,900	865	-91,033	-41,361	-38,888	-91,652	-5,355	-73,595	-54,390	18,519	-37,390	-61,307	-76,668	0	0	0
Net proceeds from common stock issued under share-based compensation plans
3,700	5,500	6,200	8,700	25,200	35,100	37,300	36,900	22,900	11,300	9,600	6,000	9,700	10,400	69,600	94,300	90,300	94,700	37,700	30,000	43,244	78,638	79,109	64,800	79,450	40,259	49,975	57,800	32,477	41,245	32,801	25,029	35,160	25,564	25,160	25,060	11,549	23,265	19,856	22,305	0	0	0
Payment of contingent consideration recognized at acquisition
0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net proceeds from issuance of debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net proceeds from revolving credit facility
-	-	-	340,000	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayment of revolving credit facility
38,600	48,600	83,600	115,000	145,000	162,000	158,000	143,000	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Excess tax benefit from share-based compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,400	9,191	13,108	12,786	11,100	7,744	4,869	7,451	7,900	7,261	6,327	17,616	34,193	46,846	62,627	63,513	58,831	0	0	0	-	-	-	-
Repurchase and retirement of common stock
-	-	-	-	-	-	-	-	-	-	-	31,600	86,300	131,300	145,900	162,600	152,700	169,700	203,100	210,700	231,586	211,476	230,984	287,700	243,609	246,541	202,417	146,300	185,701	152,884	137,485	128,467	89,354	165,420	209,065	200,490	0	0	0	-	-	-	-
Net cash provided by (used in) financing activities
-38,800	-48,400	-82,100	182,300	168,800	173,900	180,400	-95,000	-117,000	-149,400	-127,300	71,800	70,900	65,400	122,700	-68,300	-44,300	-58,100	-163,700	-177,300	-179,151	-119,730	-139,089	-211,800	-156,415	-201,413	-144,991	-80,600	-145,963	-105,312	-87,068	-69,245	-7,348	-77,229	-120,392	-116,599	-194,269	-110,971	-67,785	-49,088	0	0	0
Effect of foreign exchange rates on cash and cash equivalents
-800	2,100	1,500	2,700	600	1,900	200	-800	2,200	1,900	-800	2,200	800	-1,100	1,600	-2,200	-900	-4,200	-4,400	-4,800	-7,264	-3,392	-1,804	-600	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net increase (decrease) in cash and cash equivalents
36,100	-9,400	-3,400	-17,700	-12,500	1,900	5,400	8,500	-26,400	-19,300	1,000	33,900	3,300	-26,700	-500	4,400	65,300	75,000	17,600	-700	-30,625	-11,926	-15,214	-39,300	-26,546	3,155	-10,617	17,700	7,471	-40,425	32,907	33,671	37,474	41,179	-60,629	-40,159	-34,771	7,238	32,109	29,330	0	0	0